ESC Premium Access

Welcome and introduction.

Presentation

About the speaker

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
95 presentations
11 followers

3 more presentations in this session

Emerging evidence for SGLT2i in HFrEF patients.

Speaker: Doctor P. Kumar Sahoo (Bhubaneswar, IN)

Thumbnail

SGLT2i in ESC 2021 HF management guideline - clinical implication.

Speaker: Doctor J. Kang (Seoul, KR)

Thumbnail

Discussion and live Q&A.

Thumbnail

Access the full session

Evolving role of SGLT2i in HFrEF management

Speakers: Professor C. Lam, Doctor P. Kumar Sahoo, Doctor J. Kang
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

Related content

ESC Premium Access

Universal definition of heart failure and new classifications.

29 August 2021

ESC Premium Access

SGLT2 Inhibitors in heart failure.

29 August 2021

ESC Premium Access

Impact of optimal medical treatment for the prevention of sudden cardiac death in heart failure.

29 August 2021

This platform is supported by

logo Novo Nordisk